Skip to main content

Table 2 Association of the ten studied polymorphisms with Schizophrenia assuming different genetic models

From: A new aspect on the correlation of ten SNPs in MIR and their target genes in dopaminergic pathways in schizophrenia

Polymorphism

Model

Genotype

Case, n (%)

Control, n (%)

OR (95% CI)

P-value

NRG1 /rs369770942

AA

102 (100)

98 (100)

miR-125a-3P/rs143525573

GG

102 (100)

98 (100)

3′UTR DRD2

rs200982455

CC

TT

101 (99)

1 (0.01)

95 (97)

3 (0.03)

1

3.19 (0.33–31.20)

0.28

MIR326

rs530404895

CC

102 (100)

98 (100)

MIR326

rs753764536

GG

102 (100)

98 (100)

MIR326

rs374732351

GG

102 (100)

98 (100)

3′UTR COMT rs4680

AA

102 (100)

98 (100)

3′UTR COMT rs165599

Codominant

AA

AG

GG

47 (46.1%)

45 (44.1%)

10 (9.8%)

28 (28.6%)

63 (64.3%)

7 (7.1%)

1.00

2.35 (1.28–4.30)

1.17 (0.40–3.44)

0.016

dominant

AA

AG/ GG

47 (46.1%)

55 (53.9%)

28 (28.6%)

70 (71.4%)

1.00

2.14 (1.19–3.84)

0.01

Recessive

AA/AG

GG

92 (90.2%)

10 (9.8%)

91 (92.9%)

7 (7.1%)

1.00

0.71 (0.26–1.94)

0.5

Overdominant

AA/GG

AG

57 (55.9%)

45 (44.1%)

35 (35.7%)

63 (64.3%)

1.00

2.28 (1.29–4.03)

0.004

MIR124

rs340597269

TT

102 (100)

98 (100)

3′UTR RGS4

rs10759

CC

AA

82 (80.4%)

20 (19.6%)

78 (79.6%)

20 (20.4%)

1.00

1.05 (0.53–2.10)

0.89